These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20549816)

  • 1. Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases.
    Niwińska A; Murawska M; Pogoda K
    Cancer; 2010 Sep; 116(18):4238-47. PubMed ID: 20549816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology).
    Kaplan MA; Isikdogan A; Koca D; Kucukoner M; Gumusay O; Yildiz R; Dayan A; Demir L; Geredeli C; Kocer M; Arslan UY; Inal A; Unal OU; Mert AG; Bilici M; Ozkan M; Elkiran ET; Yaman S; Durnalı AG; Suner A; Alici S; Tarhan MO; Boruban C; Urakci Z; Buyukberber S
    Oncology; 2012; 83(3):141-50. PubMed ID: 22814315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea.
    Jang G; Lee SS; Ahn JH; Jung KH; Lee H; Gong G; Kim HH; Ahn SD; Son BH; Ahn SH; Kim SB
    Breast Cancer Res Treat; 2011 Jul; 128(1):171-7. PubMed ID: 21519835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis.
    Zhang Q; Chen J; Yu X; Cai G; Yang Z; Cao L; Hu C; Guo X; Sun J; Chen J
    Breast Cancer; 2016 Sep; 23(5):732-9. PubMed ID: 26267412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma Knife radiosurgery for brain metastases from primary breast cancer.
    Kased N; Binder DK; McDermott MW; Nakamura JL; Huang K; Berger MS; Wara WM; Sneed PK
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1132-40. PubMed ID: 19345514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT).
    Niwińska A; Murawska M; Pogoda K
    Ann Oncol; 2010 May; 21(5):942-8. PubMed ID: 19840953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.
    Heitz F; Harter P; Lueck HJ; Fissler-Eckhoff A; Lorenz-Salehi F; Scheil-Bertram S; Traut A; du Bois A
    Eur J Cancer; 2009 Nov; 45(16):2792-8. PubMed ID: 19643597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death.
    Niwińska A; Tacikowska M; Murawska M
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1134-9. PubMed ID: 19932944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype.
    Arvold ND; Oh KS; Niemierko A; Taghian AG; Lin NU; Abi-Raad RF; Sreedhara M; Harris JR; Alexander BM
    Breast Cancer Res Treat; 2012 Nov; 136(1):153-60. PubMed ID: 22968656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients.
    Wolstenholme V; Hawkins M; Ashley S; Tait D; Ross G
    Breast; 2008 Dec; 17(6):661-5. PubMed ID: 18571923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. γ knife radiosurgery of brain metastasis from breast cancer.
    Padovani L; Muracciole X; Régis J
    Prog Neurol Surg; 2012; 25():156-62. PubMed ID: 22236677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.
    Skarlos P; Christodoulou C; Kalogeras KT; Eleftheraki AG; Bobos M; Batistatou A; Valavanis C; Tzaida O; Timotheadou E; Kronenwett R; Wirtz RM; Kostopoulos I; Televantou D; Koutselini E; Papaspirou I; Papadimitriou CA; Pectasides D; Gogas H; Aravantinos G; Pavlidis N; Arapantoni P; Skarlos DV; Fountzilas G
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):533-46. PubMed ID: 21901395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
    Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
    Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
    Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
    Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
    Yue X; Zang QC
    Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases.
    Bai B; Yuan ZY; Liu DG; Teng XY; Wang SS
    Chin J Cancer; 2010 Apr; 29(4):413-9. PubMed ID: 20346218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?
    Nieder C; Pawinski A; Molls M
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):65-9. PubMed ID: 19762219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results of whole brain radiotherapy with concurrent trastuzumab for treatment of brain metastases in breast cancer patients.
    Chargari C; Idrissi HR; Pierga JY; Bollet MA; Diéras V; Campana F; Cottu P; Fourquet A; Kirova YM
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):631-6. PubMed ID: 20932686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.